Founded by Drs. Kenneth Greenberg, Michael Davidson, and Steve Feinstein, SonoThera, Inc. is a biotechnology company dedicated to treating the root cause of human disease through genetic therapy. SonoThera is developing an ultrasound-guided, nonviral gene therapy platform and treatments designed to provide patients with the next generation of safe and effective genetic medicines. The platform utilizes sonoporation, a microbubble-mediated biophysical process to non-invasively deliver genetic payloads selectively targeting a wide range of organs within the body.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
12/05/22	$60,750,000	Series A	Alexandria Venture Investments ARCH Venture Partners Eli Lilly and Company Foothill Ventures Formic Ventures Illumina Ventures Johnson & Johnson Development Corporation (JJDC) Lifespan Investments Medical Excellence Capital Vertex Ventures Wilson, Sonsini, Goodrich and Rosati	undisclosed